By leading the manuscript development, Veranex supported Philips Healthcare in publishing real-world evidence data supporting the use of Mobile Cardiac Monitoring after a TAVR procedure.[dpvfw_pdf_viewer_embed _builder_version="4.18.0" _module_preset="default"...
Demonstrating Clinical Utility Using a Validated Methodology From the Market Research Toolkit
Veranex Director Lauren Fusfeld uses a case study to show how conjoint analysis can demonstrate to payers and health care providers the clinical utility of a prognostic test. Lauren's article is featured on page 30.
Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom
By developing a cost-effectiveness model and associated manuscript for home non-invasive ventilation in patients with persistent hypercapnia after an acute exacerbation of COPD, Veranex bolstered the economic argument for home non-invasive ventilation in the UK. The...